AstraZeneca's Imjudo finally snags first approval—only in an ever-crowded liver cancer field
24th October 2022 Uncategorised 0 AstraZeneca’s Imjudo finally snags first approval—only in an ever-crowded liver cancer field
aliu
Mon, 10/24/2022 – 10:07
More: AstraZeneca's Imjudo finally snags first approval—only in an ever-crowded liver cancer field
Source: fierce
